ICUROS study finds international variations in quality of life loss after fracture

March 24, 2011

A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables.

The quality of life (QoL) of patients who sustained a hip, wrist or vertebral fracture was examined for the four months following the fracture. The study is part of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) which is an international patient-based study endorsed by the International Osteoporosis Foundation. ICUROS investigates the costs and health effects of osteoporotic fractures in women and men over the age of fifty. The aim is to gather better information regarding the burden of osteoporosis in the participating countries and worldwide. Currently, eleven countries are involved in ICUROS.

Involving 2,737 patients from nine countries, the study found that quality of life loss over four months was highest for hip fractures, followed by vertebral and wrist fractures. Interestingly, significant variations between countries were identified. Quality of life loss after hip fracture was greatest in Lithuania, followed by Italy, Russia and Mexico. Lower quality of life loss was experienced by hip fracture patients in Austria and Sweden. In all countries in which vertebral fractures were studied, patients who were hospitalized experienced more quality of life loss than those who were not hospitalized following vertebral fracture.
-end-
The abstract 'Quality of life four months following a fracture - results from the ICUROS', F. Borgström, et al. (OC14) is published in supplement issue of Osteoporosis International. DOI 10.1007/s00198-011-1554-9ABOUT ICUROS

The International Costs and Utilities Related to Osteoporotic Fractures Study - is an international patient based study investigating the costs and health effects of osteoporotic fractures. The intention is to include as many countries as possible to investigate potential differences in quality of life and fracture related costs. The ICUROS will lead to better information regarding the burden of osteoporosis in the participating countries and worldwide, which will increase the awareness of osteoporosis. The ICUROS is endorsed by the International Osteoporosis Foundation and is administered by i3 innovus, Sweden (formerly European Health Economics). http://www.medscinet.com/icuros/

ABOUT IOF

The International Osteoporosis Foundation (IOF) is a nongovernmental umbrella organization dedicated to the worldwide fight against osteoporosis, the disease known as "the silent epidemic". IOF's members - committees of scientific researchers, patient, medical and research societies and industry representatives from around the world - share a common vision of a world without osteoporotic fractures. IOF now represents 196 societies in 92 locations. http://www.iofbonehealth.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.